Edinburgh Research Explorer

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis

Research output: Contribution to journalArticle

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: Copyright © 2012 Elsevier Ltd. All rights reserved. This document may be redistributed and reused, subject to certain conditions.

    Final published version, 328 KB, PDF document

Original languageEnglish
Pages (from-to)2364-72
Number of pages9
JournalThe Lancet
Volume379
Issue number9834
DOIs
Publication statusPublished - 2012

Abstract

Recombinant tissue plasminogen activator (rt-PA, alteplase) improved functional outcome in patients treated soon after acute ischaemic stroke in randomised trials, but licensing is restrictive and use varies widely. The IST-3 trial adds substantial new data. We therefore assessed all the evidence from randomised trials for rt-PA in acute ischaemic stroke in an updated systematic review and meta-analysis.

Download statistics

No data available

ID: 5430322